Target intelligence / Profile preview

Salmonella paratyphi A O-antigen polysaccharide (O:2 antigen)

Target
O:2 antigen
Molecular classification
Bacterial surface antigen, Other
01

Overview

Salmonella paratyphi A O-antigen polysaccharide is a critical somatic antigen located on the outer membrane of the Gram-negative bacterium Salmonella enterica serovar Paratyphi A [1, 12]. It is a key component of the lipopolysaccharide (LPS) and consists of a repeating trisaccharide backbone of rhamnose, mannose, and galactose, with a paratose side chain that defines the O:2 serospecificity [3, 8]. This polysaccharide plays a vital role in bacterial virulence and serves as the primary target for the development of conjugate vaccines against paratyphoid fever, a major cause of enteric fever in South and Southeast Asia [1, 4]. Because the O-antigen alone is T-cell independent and poorly immunogenic in infants, it is typically conjugated to carrier proteins like tetanus toxoid or CRM197 to induce a robust, T-cell dependent immune response [2, 9]. Current therapeutic strategies focus on bivalent vaccines that combine this O-antigen with the Vi antigen of Salmonella Typhi to provide broad protection against enteric fever [6, 7]. Clinical candidates such as O:2-CRM197 have demonstrated the ability to elicit antibodies with potent bactericidal activity against diverse clinical isolates [3, 16].

Other names
Salmonella Paratyphi A O-polysaccharideSPA O-antigenO:2 somatic antigenO-specific polysaccharide (OPS)Salmonella enterica serovar Paratyphi A lipopolysaccharide O-antigen
02

Mechanism of action

Induction of protective IgG antibodies that facilitate serum bactericidal activity and opsonophagocytosis against Salmonella Paratyphi A.

03

Biological functions

Immune responseOther
04

Disease associations

Infection
05

Safety considerations

Injection site reactionsHypersensitivityStructural heterogeneity (O-acetylation and glucosylation levels) affecting immunogenicity
06

Interacting drugs

O:2-CRM197 (conjugate vaccine candidate)

3 more in the full profile.

07

Biomarkers

Anti-O:2 IgG antibody titersSerum bactericidal activity (SBA) titers

Beyond the preview

Go deeper on Salmonella paratyphi A O-antigen polysaccharide (O:2 antigen).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salmonella paratyphi A O-antigen polysaccharide (O:2 antigen).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call